204 related articles for article (PubMed ID: 38201249)
1. The Role of Apoptosis and Oxidative Stress in a Cell Spheroid Model of Calcific Aortic Valve Disease.
Coutts CW; Baldwin AM; Jebeli M; Jolin GE; Mungai RW; Billiar KL
Cells; 2023 Dec; 13(1):. PubMed ID: 38201249
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
3. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
[TBL] [Abstract][Full Text] [Related]
4. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
[TBL] [Abstract][Full Text] [Related]
5. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
[TBL] [Abstract][Full Text] [Related]
6. The role of neutrophil elastase in aortic valve calcification.
Liu Y; Jiang P; An L; Zhu M; Li J; Wang Y; Huang Q; Xiang Y; Li X; Shi Q; Weng Y
J Transl Med; 2022 Apr; 20(1):167. PubMed ID: 35397552
[TBL] [Abstract][Full Text] [Related]
7. Comparison of calcification potential of valvular interstitial cells isolated from individual aortic valve cusps.
Masjedi S; Amarnath A; Baily KM; Ferdous Z
Cardiovasc Pathol; 2016; 25(3):185-194. PubMed ID: 26874039
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.
Tanase DM; Valasciuc E; Gosav EM; Floria M; Costea CF; Dima N; Tudorancea I; Maranduca MA; Serban IL
Cells; 2022 Aug; 11(17):. PubMed ID: 36078071
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin Sulfate Promotes Interstitial Cell Activation and Calcification in an In Vitro Model of the Aortic Valve.
Dahal S; Bramsen JA; Alber BR; Murray BT; Huang P; Chen MH; Mahler GJ
Cardiovasc Eng Technol; 2022 Jun; 13(3):481-494. PubMed ID: 34735711
[TBL] [Abstract][Full Text] [Related]
10. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way.
En Q; Zeping H; Yuetang W; Xu W; Wei W
Mol Med; 2021 Dec; 27(1):156. PubMed ID: 34895136
[TBL] [Abstract][Full Text] [Related]
11. New calcification model for intact murine aortic valves.
Kruithof BPT; van de Pol V; Los T; Lodder K; Mousavi Gourabi B; DeRuiter MC; Goumans MJ; Ajmone Marsan N
J Mol Cell Cardiol; 2021 Jul; 156():95-104. PubMed ID: 33744308
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms involved in high glucose-induced valve calcification in a 3D valve model with human valvular cells.
Vadana M; Cecoltan S; Ciortan L; Macarie RD; Tucureanu MM; Mihaila AC; Droc I; Butoi E; Manduteanu I
J Cell Mol Med; 2020 Jun; 24(11):6350-6361. PubMed ID: 32307869
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Matrix in Calcific Aortic Valve Disease: Architecture, Dynamic and Perspectives.
Di Vito A; Donato A; Presta I; Mancuso T; Brunetti FS; Mastroroberto P; Amorosi A; Malara N; Donato G
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477599
[TBL] [Abstract][Full Text] [Related]
14. Reproducible in vitro model for dystrophic calcification of cardiac valvular interstitial cells: insights into the mechanisms of calcific aortic valvular disease.
Cirka HA; Uribe J; Liang V; Schoen FJ; Billiar KL
Lab Chip; 2017 Feb; 17(5):814-829. PubMed ID: 28128382
[TBL] [Abstract][Full Text] [Related]
15. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
[TBL] [Abstract][Full Text] [Related]
16. Biophysical analysis of dystrophic and osteogenic models of valvular calcification.
Chen J; Peacock JR; Branch J; David Merryman W
J Biomech Eng; 2015 Feb; 137(2):020903. PubMed ID: 25405546
[TBL] [Abstract][Full Text] [Related]
17. Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.
Greenberg HZE; Zhao G; Shah AM; Zhang M
Cardiovasc Res; 2022 May; 118(6):1433-1451. PubMed ID: 33881501
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous multi-laminar tissue constructs as a platform to evaluate aortic valve matrix-dependent pathogenicity.
Monroe MN; Nikonowicz RC; Grande-Allen KJ
Acta Biomater; 2019 Oct; 97():420-427. PubMed ID: 31362141
[TBL] [Abstract][Full Text] [Related]
19. Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells.
Masjedi S; Lei Y; Patel J; Ferdous Z
Heart Vessels; 2017 Feb; 32(2):217-228. PubMed ID: 27761653
[TBL] [Abstract][Full Text] [Related]
20. Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1/5/8/NF-κB/ERK pathway.
Wang Y; Weng Y; Li X; Huang Q; Xiang Y; Li X; Shi Q
Biomed Pharmacother; 2021 Jul; 139():111674. PubMed ID: 34243610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
